# OnCo record cctg-ce6 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/cctg-ce6/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "cctg-ce6", "NCT00482677" ;
  schema:name "CCTG CE.6 / EORTC 26062-22061 (Perry trial)"@en ;
  schema:description "The trial that set treatment for older patients with glioblastoma: three weeks of radiotherapy instead of six, with temozolomide added, extended survival without worsening quality of life."@en ;
  schema:url <https://onco.cc/trials/cctg-ce6/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00482677>, <https://doi.org/10.1056/NEJMoa1611977>, <https://doi.org/10.1016/S1470-2045(12)70265-6>, <https://doi.org/10.1016/S1470-2045(12)70164-X> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2007-11-14" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> ;
  onco:companies <https://onco.cc/companies/cctg/>, <https://onco.cc/companies/curie-nki-eortc/>, <https://onco.cc/companies/trog/> ;
  onco:terms <https://onco.cc/terms/mgmt/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-malmstrom-lancet-oncol/>, <https://onco.cc/key-papers/paper-perry-n-engl-j-med/> .